One small biotech holds the key to a revolution in treating Alzheimer's disease. Jeff Bezos, Goldman Sachs & Big Pharma giants have invested billions into this unknown biotech. Our research proves that anyone who gets in today could see gains as high as 113,000%!

Michael Linton Biography and Net Worth

Director of loanDepot

Mike Linton has served as a director of the company since 2021 and brings significant marketing and strategy expertise in consumer financial services and technology. Linton currently serves as the chief revenue officer of Ancestry, the global leader in family history and consumer genomics, which he joined in 2019. He previously served as chief marketing officer of Farmers Insurance beginning in 2011. Earlier in his career, Linton held senior executive positions at several companies, including chief marketing officer of eBay from 2007 until 2009 and the first chief marketing officer of Best Buy from 1999 to 2006 as well as leadership roles at Procter & Gamble and Progressive Insurance. Linton currently sits on the board of directors of Medical Solutions and The Wine Group and advises several early-stage companies. He previously served on the boards of Peet’s Coffee & Tea, Allen Edmonds, and Capella Education. Linton received his undergraduate degree from Bowling Green State University and his MBA from Duke's Fuqua School of Business.

How do I contact Michael Linton?: The corporate mailing address for Mr. Linton and other loanDepot executives is 26642 TOWNE CENTRE DRIVE, FOOTHILL RANCH CA, 92610. loanDepot can also be reached via phone at 888-337-6888 and via email at [email protected]. Learn More on Michael Linton's contact information.
Has Michael Linton been buying or selling shares of loanDepot?: Michael Linton has not been actively trading shares of loanDepot in the last ninety days. Most recently, on Friday, August 6th, Michael Linton bought 7,520 shares of loanDepot stock. The stock was acquired at an average cost of $9.43 per share, with a total value of $70,913.60. Learn More on Michael Linton's trading history.
Who are loanDepot's active insiders?: loanDepot's insider roster includes Patrick Flanagan (CFO), Anthony Hsieh (CEO), Michael Linton (Director), and Pamela Patenaude (Director). Learn More on loanDepot's active insiders.
Are insiders buying or selling shares of loanDepot?: During the last twelve months, loanDepot insiders bought shares 7 times. They purchased a total of 105,207 shares worth more than $193,013.94. During the last twelve months, insiders at the sold shares 36 times. They sold a total of 836,583 shares worth more than $1,757,524.75. The most recent insider tranaction occured on March, 20th when Director Dan Binowitz sold 13,900 shares worth more than $32,526.00. Insiders at loanDepot own 83.9% of the company. Learn More about insider trades at loanDepot.
Information on this page was last updated on 3/20/2024.

Michael Linton Insider Trading History at loanDepot

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction	Details
8/6/2021	Buy	7,520	$9.43	$70,913.60

Michael Linton Buying and Selling Activity at loanDepot

loanDepot Company Overview

loanDepot, Inc. engages in originating, financing, selling, and servicing residential mortgage loans in the United States. The company offers conventional agency-conforming and prime jumbo, federal assistance residential mortgage, and home equity loans. It also provides settlement services, which include captive title and escrow business; real estate services that cover captive real estate referral business; and insurance services, including services to homeowners, as well as other consumer insurance policies. The company was founded in 2010 and is headquartered in Irvine, California.

Today's Range

Now: $2.37

$2.32

$2.41

50 Day Range

MA: $2.49

$2.14

$2.77

2 Week Range

Now: $2.37

$1.14

$3.71

Volume

35,914 shs

Average Volume

440,757 shs

Market Capitalization

$765.72 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

3.13

The World's First "$20 Trillion Drug?"

From Behind the Markets | Ad

Get the name of the stock here >>>